Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II study of brilacidin for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS)

X
Trial Profile

Phase II study of brilacidin for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 17 Dec 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Brilacidin (Primary) ; Brilacidin (Primary)
  • Indications Ulcerative colitis; Ulcerative proctitis; Ulcerative proctosigmoiditis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Innovation Pharmaceuticals
  • Most Recent Events

    • 14 Jan 2019 According to an Innovation Pharmaceuticals media release, in late 2018 the company presented data as a scientific poster at the inaugural IBD Innovate 2018 conference, hosted by the Crohns & Colitis Foundation.
    • 20 Sep 2018 Status changed from active, no longer recruiting to completed, according to an Innovation Pharmaceuticals media release.
    • 13 Jul 2017 Results from this trial have been presented at the Drug Discovery & Therapy World Congress, according to an Innovation Pharmaceuticals media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top